Want to see SG:M15 full AI Analyst Report?
Top Page
Matex International Limited
(SGX:M15)
Select Model
Select Model
Rating:43Neutral
Price Target:
S$0.02
▲(5.00% Upside)
Action:Reiterated
Date:09/24/26
The score is held down primarily by weak financial performance: large losses, heavy negative operating/free cash flow, and increased leverage. Technicals are also soft with weak momentum signals, while valuation is constrained by a negative P/E and no dividend yield data.
Positive Factors
Revenue Recovery
The sharp TTM revenue rebound indicates renewed commercial activity and demonstrates that the company still has demand for its products. If maintained, stronger sales can improve operating leverage and provide a foundation for restoring profitability over the next several quarters.
Negative Factors
Deep Unprofitability
Severe operating and net losses show that the recent revenue rebound has not translated into an economically sustainable business model. Persistently negative margins can erode equity, restrict reinvestment, and make future growth less valuable unless costs and pricing improve materially.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery
The sharp TTM revenue rebound indicates renewed commercial activity and demonstrates that the company still has demand for its products. If maintained, stronger sales can improve operating leverage and provide a foundation for restoring profitability over the next several quarters.
Read all positive factors
Matex International Limited (M15) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$11.35M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)0.16
Revenue Growth25.81%
EPS Growth-30.34%
CountrySG
Employees65
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.02
Shares Outstanding515,698,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.83
Price to Sales (P/S)1.89
P/FCF Ratio-2.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Matex International Limited Business Overview & Revenue Model
Company Description
Matex International Limited, headquartered in Singapore since its establishment in 1989, specializes in the development, production, and distribution of a diverse range of specialized chemical compounds. The company's operations extend across Sing...
Matex International Limited Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
44
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.44M | 5.86M | 7.00M | 7.35M | 14.59M | 20.93M |
| Gross Profit | 1.60M | 865.00K | 1.47M | 1.61M | 2.51M | 2.64M |
| EBITDA | -5.89M | -6.51M | -2.55M | -3.23M | 5.39M | -5.01M |
| Net Income | -8.97M | -6.77M | -2.65M | -3.31M | 7.27M | -4.93M |
Balance Sheet | ||||||
| Total Assets | 14.67M | 11.85M | 15.24M | 21.40M | 24.25M | 30.22M |
| Cash, Cash Equivalents and Short-Term Investments | 9.45M | 8.36M | 8.86M | 16.37M | 11.92M | 5.66M |
| Total Debt | 5.68M | 1.87M | 1.49M | 3.20M | 4.40M | 6.12M |
| Total Liabilities | 11.93M | 7.82M | 7.29M | 9.15M | 9.15M | 23.14M |
| Stockholders Equity | 4.85M | 6.05M | 9.05M | 12.70M | 14.88M | 7.80M |
Cash Flow | ||||||
| Free Cash Flow | -6.57M | -5.28M | -2.97M | -754.00K | -1.25M | -35.00K |
| Operating Cash Flow | -6.32M | -5.19M | -2.40M | -456.00K | -1.17M | 238.00K |
| Investing Cash Flow | 139.50K | 171.00K | -3.23M | 3.82M | 11.77M | -267.00K |
| Financing Cash Flow | 4.88M | 4.72M | -1.88M | 1.12M | -4.82M | 1.91M |
Matex International Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | S$606.56M | 7.58 | 9.08% | 4.32% | 4.17% | -12.40% | |
65 Neutral | S$42.53M | -31.46 | -0.88% | 0.89% | -7.25% | 95.72% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
45 Neutral | S$13.32M | -12.50 | -81.29% | ― | ― | ― | |
43 Neutral | S$11.35M | -1.30 | -164.44% | ― | 25.81% | -30.34% | |
42 Neutral | S$31.82M | -0.70 | -48.10% | 23.34% | -69.91% | -13.56% |
* Basic Materials Sector Average
SG:M15
Matex International Limited
0.02
0.00
0.00%
SG:QES
China Sunsine Chemical Holdings Ltd.
0.62
-0.12
-15.88%
SG:C05
Chemical Industries Far East Ltd.
0.56
<0.01
0.90%
SG:5DS
MegaChem Ltd.
0.45
0.00
0.00%
SG:5WV
AsiaPhos Limited
0.01
0.00
0.00%
SG:C8R
Jiutian Chemical Group Limited
0.02
-0.01
-46.67%
Matex International Limited Corporate Events
Nanyang New Development strengthens board independence with new director appointment
Jul 24, 2026
Nanyang New Development Limited has appointed Ms. Sim Kai Li as an independent director effective 25 July 2026, reinforcing its board independence in line with Catalist listing requirements. She will serve as chair of the Nominating Committee and ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.